麻豆原创

Published on 麻豆原创 Research Reports庐 Inc. ()

麻豆原创 > Global Hematology Quality Controls 麻豆原创 Research Report 2025

Global Hematology Quality Controls 麻豆原创 Research Report 2025

Publication ID: 
PB506253065
Publication Date: 
June 18, 2025
Pages: 
96
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Medical Devices [2]
Pharma & Healthcare [3]
Description: 

The global market for Hematology Quality Controls was valued at US$ 505 million in the year 2024 and is projected to reach a revised size of US$ 770 million by 2031, growing at a CAGR of 6.2% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hematology Quality Controls competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hematology Quality Controls are specialized quality control substances used to monitor the stability of the detection process of blood analyzers (such as blood routine testing equipment) and evaluate the performance of the detection system. Its core goal is to ensure that the blood analyzer provides accurate, reliable, and reproducible test results for patient samples at different times, batches of reagents, or operating conditions. It is one of the core tools of the quality management system for blood testing laboratories.
North American market for Hematology Quality Controls is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hematology Quality Controls is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hematology Quality Controls include Bio-Rad, Streck, Thermo Fisher Scientific, Randox Laboratories, Sysmex, Fortress Diagnostics, Bio-Techne, Diatron, Changchun DIRUI, Shenzhen Mindray, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hematology Quality Controls, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Quality Controls.
The Hematology Quality Controls market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hematology Quality Controls market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Quality Controls manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bio-Rad
Streck
Thermo Fisher Scientific
Randox Laboratories
Sysmex
Fortress Diagnostics
Bio-Techne
Diatron
Changchun DIRUI
Shenzhen Mindray
Sichuan ZCMT
Segment by Type
High Level
Medium Level
Low Level
Segment by Application
Hospital
Laboratory
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hematology Quality Controls manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hematology Quality Controls in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Hematology Quality Controls 麻豆原创 Overview
1.1 Product Definition
1.2 Hematology Quality Controls by Type
1.2.1 Global Hematology Quality Controls 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 High Level
1.2.3 Medium Level
1.2.4 Low Level
1.3 Hematology Quality Controls by Application
1.3.1 Global Hematology Quality Controls 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Laboratory
1.4 Global Hematology Quality Controls 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Hematology Quality Controls Revenue 2020-2031
1.4.2 Global Hematology Quality Controls Sales 2020-2031
1.4.3 Global Hematology Quality Controls 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hematology Quality Controls 麻豆原创 Competition by Manufacturers
2.1 Global Hematology Quality Controls Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Hematology Quality Controls Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Hematology Quality Controls Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hematology Quality Controls, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hematology Quality Controls, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hematology Quality Controls, Product Type & Application
2.7 Global Key Manufacturers of Hematology Quality Controls, Date of Enter into This Industry
2.8 Global Hematology Quality Controls 麻豆原创 Competitive Situation and Trends
2.8.1 Global Hematology Quality Controls 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Hematology Quality Controls Players 麻豆原创 Share by Revenue
2.8.3 Global Hematology Quality Controls Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hematology Quality Controls 麻豆原创 Scenario by Region
3.1 Global Hematology Quality Controls 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hematology Quality Controls Sales by Region: 2020-2031
3.2.1 Global Hematology Quality Controls Sales by Region: 2020-2025
3.2.2 Global Hematology Quality Controls Sales by Region: 2026-2031
3.3 Global Hematology Quality Controls Revenue by Region: 2020-2031
3.3.1 Global Hematology Quality Controls Revenue by Region: 2020-2025
3.3.2 Global Hematology Quality Controls Revenue by Region: 2026-2031
3.4 North America Hematology Quality Controls 麻豆原创 Facts & Figures by Country
3.4.1 North America Hematology Quality Controls 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hematology Quality Controls Sales by Country (2020-2031)
3.4.3 North America Hematology Quality Controls Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hematology Quality Controls 麻豆原创 Facts & Figures by Country
3.5.1 Europe Hematology Quality Controls 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hematology Quality Controls Sales by Country (2020-2031)
3.5.3 Europe Hematology Quality Controls Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hematology Quality Controls 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Hematology Quality Controls 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hematology Quality Controls Sales by Region (2020-2031)
3.6.3 Asia Pacific Hematology Quality Controls Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hematology Quality Controls 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Hematology Quality Controls 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hematology Quality Controls Sales by Country (2020-2031)
3.7.3 Latin America Hematology Quality Controls Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Hematology Quality Controls 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Hematology Quality Controls 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hematology Quality Controls Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hematology Quality Controls Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hematology Quality Controls Sales by Type (2020-2031)
4.1.1 Global Hematology Quality Controls Sales by Type (2020-2025)
4.1.2 Global Hematology Quality Controls Sales by Type (2026-2031)
4.1.3 Global Hematology Quality Controls Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Hematology Quality Controls Revenue by Type (2020-2031)
4.2.1 Global Hematology Quality Controls Revenue by Type (2020-2025)
4.2.2 Global Hematology Quality Controls Revenue by Type (2026-2031)
4.2.3 Global Hematology Quality Controls Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Hematology Quality Controls Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hematology Quality Controls Sales by Application (2020-2031)
5.1.1 Global Hematology Quality Controls Sales by Application (2020-2025)
5.1.2 Global Hematology Quality Controls Sales by Application (2026-2031)
5.1.3 Global Hematology Quality Controls Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Hematology Quality Controls Revenue by Application (2020-2031)
5.2.1 Global Hematology Quality Controls Revenue by Application (2020-2025)
5.2.2 Global Hematology Quality Controls Revenue by Application (2026-2031)
5.2.3 Global Hematology Quality Controls Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Hematology Quality Controls Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bio-Rad
6.1.1 Bio-Rad Company Information
6.1.2 Bio-Rad Description and Business Overview
6.1.3 Bio-Rad Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bio-Rad Hematology Quality Controls Product Portfolio
6.1.5 Bio-Rad Recent Developments/Updates
6.2 Streck
6.2.1 Streck Company Information
6.2.2 Streck Description and Business Overview
6.2.3 Streck Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Streck Hematology Quality Controls Product Portfolio
6.2.5 Streck Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Company Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Thermo Fisher Scientific Hematology Quality Controls Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 Randox Laboratories
6.4.1 Randox Laboratories Company Information
6.4.2 Randox Laboratories Description and Business Overview
6.4.3 Randox Laboratories Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Randox Laboratories Hematology Quality Controls Product Portfolio
6.4.5 Randox Laboratories Recent Developments/Updates
6.5 Sysmex
6.5.1 Sysmex Company Information
6.5.2 Sysmex Description and Business Overview
6.5.3 Sysmex Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sysmex Hematology Quality Controls Product Portfolio
6.5.5 Sysmex Recent Developments/Updates
6.6 Fortress Diagnostics
6.6.1 Fortress Diagnostics Company Information
6.6.2 Fortress Diagnostics Description and Business Overview
6.6.3 Fortress Diagnostics Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fortress Diagnostics Hematology Quality Controls Product Portfolio
6.6.5 Fortress Diagnostics Recent Developments/Updates
6.7 Bio-Techne
6.7.1 Bio-Techne Company Information
6.7.2 Bio-Techne Description and Business Overview
6.7.3 Bio-Techne Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio-Techne Hematology Quality Controls Product Portfolio
6.7.5 Bio-Techne Recent Developments/Updates
6.8 Diatron
6.8.1 Diatron Company Information
6.8.2 Diatron Description and Business Overview
6.8.3 Diatron Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Diatron Hematology Quality Controls Product Portfolio
6.8.5 Diatron Recent Developments/Updates
6.9 Changchun DIRUI
6.9.1 Changchun DIRUI Company Information
6.9.2 Changchun DIRUI Description and Business Overview
6.9.3 Changchun DIRUI Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Changchun DIRUI Hematology Quality Controls Product Portfolio
6.9.5 Changchun DIRUI Recent Developments/Updates
6.10 Shenzhen Mindray
6.10.1 Shenzhen Mindray Company Information
6.10.2 Shenzhen Mindray Description and Business Overview
6.10.3 Shenzhen Mindray Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shenzhen Mindray Hematology Quality Controls Product Portfolio
6.10.5 Shenzhen Mindray Recent Developments/Updates
6.11 Sichuan ZCMT
6.11.1 Sichuan ZCMT Company Information
6.11.2 Sichuan ZCMT Description and Business Overview
6.11.3 Sichuan ZCMT Hematology Quality Controls Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sichuan ZCMT Hematology Quality Controls Product Portfolio
6.11.5 Sichuan ZCMT Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hematology Quality Controls Industry Chain Analysis
7.2 Hematology Quality Controls Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hematology Quality Controls Production Mode & Process Analysis
7.4 Hematology Quality Controls Sales and 麻豆原创ing
7.4.1 Hematology Quality Controls Sales Channels
7.4.2 Hematology Quality Controls Distributors
7.5 Hematology Quality Controls Customer Analysis
8 Hematology Quality Controls 麻豆原创 Dynamics
8.1 Hematology Quality Controls Industry Trends
8.2 Hematology Quality Controls 麻豆原创 Drivers
8.3 Hematology Quality Controls 麻豆原创 Challenges
8.4 Hematology Quality Controls 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned: 

Bio-Rad
Streck
Thermo Fisher Scientific
Randox Laboratories
Sysmex
Fortress Diagnostics
Bio-Techne
Diatron
Changchun DIRUI
Shenzhen Mindray
Sichuan ZCMT

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-hematology-quality-controls-market-research-report-2025

Links
[1] /countries/global[2] /medical-devices[3] /pharma-healthcare